Page last updated: 2024-11-06

hydroxyproline and Carcinoma, Intraductal, Noninfiltrating

hydroxyproline has been researched along with Carcinoma, Intraductal, Noninfiltrating in 2 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Carcinoma, Intraductal, Noninfiltrating: A noninvasive (noninfiltrating) carcinoma of the breast characterized by a proliferation of malignant epithelial cells confined to the mammary ducts or lobules, without light-microscopy evidence of invasion through the basement membrane into the surrounding stroma.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marotta, M1
Martino, G1
D'Armiento, FP1
Aiello, AM1
Roberti, ML1
Vecchione, R1
Rosati, P1
Radom, S1
Zulawski, M1
Golebiowska, D1

Other Studies

2 other studies available for hydroxyproline and Carcinoma, Intraductal, Noninfiltrating

ArticleYear
Collagen in human breast cancer: morphological and biochemical study.
    Applied pathology, 1985, Volume: 3, Issue:3

    Topics: Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Collagen; Electrophoresis, Polyac

1985
Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
    Polish medical journal, 1972, Volume: 11, Issue:4

    Topics: Alkaline Phosphatase; Bone Neoplasms; Breast Neoplasms; Calcium; Carcinoma, Intraductal, Noninfiltra

1972